|
|
Office Locations:
|
400 Crown Colony Drive, Suite 104
Quincy, MA 02169
Phone: 617-472-2805
Fax: 617-472-3531
| |
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
NMT Capital (formerly Nexus) is a globally oriented private equity firm. It is currently managing three investment funds: two based in Europe and one in the U.S., and its portfolio companies are located in both continents. They are carefully selected from among a wide universe of potential investment opportunities to possess the best technology or business strategy available globally. Founded in 2004 as Nexus Medical Partners, Nexus has expanded its investment strategy to include IT investments as well. It is managed by three Principals who are supported by Advisors and affiliates in Quincy (MA), San Francisco, London, Munich, Geneva and Tokyo. The Principals of Nexus have experience investing in companies in various stages of development, across sectors including medical devices, diagnostics, biotechnology, specialty pharmaceutical, drug discovery tools, software, communications and information technology and advanced materials. The firm is active globally and will consider not only domestic investments, but also offshore (ex-US) investments in companies located in Europe and the Middle East who are seeking to penetrate the U.S. market.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|
|
Name | |
| |
Title | |
Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
|
Edwin Snape | |
Ph.D. | |
Co-Founder | |
Gregory F. Zaic | |
| |
Principal | |
John F. Rousseau | |
| |
Co-Founder & Principal | |
Thomas E. Hancock | |
| |
Principal | |
|
|
|
|
- This RSS feed URL is deprecated
- With An ROE Of 5.63%, Has Neometals Ltd's (ASX:NMT) Management Done A Good Job? - Simply Wall St
- The rich still getting richer. And the poor? - Business Day
- Inside Sango Ntsaluba's entrepreneurial success - DestinyMan
- Nationalisation of SA's central bank will not deliver miracles - Business Day
- Old Mutual Emerging Markets has a new CEO - CNBCAfrica.com
- Meet Sango Ntsaluba, founder of South Africa's first black-owned audit firm - 702
- Energy Jobs: Green Charge, PG&E, Edison International, Greenworks, Vivint Solar, SolarCity, UBS - Greentech ...
- Proterra Raises $55 Million for Electric Buses - Greentech Media
- Energy Jobs: Apple, SolarCity, Ethical Electric, NRStor, Proterra, GT Advanced Technologies - Greentech Media
|
|
|